Bull
$28.55
Scenario price
$14.590
+0.286 (+1.96%)At close
Afya Ltd is a Brazil-based company engaged in the education sector. The Company is mainly focused on operating medical schools, offering health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition and biomedicine. In addition, the Firm provides degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering and pedagogy. The Company's methodological approach combines integrated content, interactive learning, and an adaptive experience for learners. Through its educational content and technology-enabled activities, the Company focuses on personalized learning that mirrors one-on-one tutoring. The Company's undergraduate and graduate campuses are spread across Brazil, as well as its digital medical platform.
Afya Ltd is a good buy right now due to its strong revenue growth of 8% in the latest earnings report, reaching BRL 1.013 billion, and a low forward P/E ratio of 7.13, indicating potential undervaluation. However, the main risk is the significant insider selling, which has increased by 1215.03% over the last month, suggesting potential concerns about the company's future performance.
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Afya Initiates Early Discussions for Potential Merger with Yduqs

Afya Limited Reports Steady Growth in H1 2026 Financial Results

Afya Appoints New Chair of Audit Committee

Afya Releases 2025 Integrated Report Highlighting Operational Excellence

Afya Announces 2026 Annual General Meeting Details
Afya Ltd is a Brazil-based company engaged in the education sector. The Company is mainly focused on operating medical schools, offering health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition and biomedicine. In addition, the Firm provides degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering and pedagogy. The Company's methodological approach combines integrated content, interactive learning, and an adaptive experience for learners. Through its educational content and technology-enabled activities, the Company focuses on personalized learning that mirrors one-on-one tutoring. The Company's undergraduate and graduate campuses are spread across Brazil, as well as its digital medical platform. It operates in the Academic & Educational Services sector.
Afya Ltd is a good buy right now due to its strong revenue growth of 8% in the latest earnings report, reaching BRL 1.013 billion, and a low forward P/E ratio of 7.13, indicating potential undervaluation. However, the main risk is the significant insider selling, which has increased by 1215.03% over the last month, suggesting potential concerns about the company's future performance.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.